|
Sign Up for our Penny Stock Newsletter:
* By Clicking 'Sign Up', you Agree to our Disclaimer and Privacy Policy It's 100% Free, 100% Anti-Spam and you may Unsubscribe at Any Time! |
|
Posted on 06 May 2014.
Caribbean International Holdings, Inc. (CIHN) has recently Changed Company Direction to direct its full focus on Regenerative and Personalized Medicine by providing Adult Stem Cell Incubation and Storage for individuals seeking to protect and ensure their quality of life in the future.
There are different kinds of stem cells found in the body that can be utilized for different purposes, however adult stem cells found within a tissue or organ are able to divide itself indefinitely, renew dying cells, and regenerate damaged tissues. As so, adult stem cells have been widely used in human therapies for many years as they are proving to be a solution to over 100 global diseases and conditions.
Through its subsidiary, Regenerative Bio Science, CIHN is utilizing adult stem cells to treat cardiac and vascular patients with health problems including coronary heart disease, peripheral artery disease, congestive heart failure, pulmonary fibrosis, and chronic obstructive pulmonary diseases to limit the number of patients who require bypasses, stents, angiograms, angioplasties and other standard invasive treatments. As heart and lung diseases worsen, these procedures have a limited benefit to the overall health of the patient.
By extracting adult stem cells from a patient’s own blood or bone marrow, said to contain the necessary stem cell to repair and regenerate muscle and form new blood vessels, CIHN is offering patients to improve their quality of life and heal their body in a natural manner. For example, instead of utilizing steroids, neulizer treatments, or bronchodilators to treat the symptoms of pulmonary patients, adult stem cells can repair or replace damaged lung tissue in the bronchioles and alveoli. Likewise, patients with cardiovascular problems could avoid hazardous and unsustainable alternatives such as a pacemaker and defibrillator. Furthermore, the company will extend its patient research to see how stem cells may assist brain injuries including chronic traumatic encephalopathy.
Symbol: CIHN [ Current PPS: $0.0299 Outstanding Shares: 975M Float: 33.5M – a/o May 6, 2014 ]
Website(s): www.regenerativebioscience.com
Get Updates on CIHN and other Hot Penny Stocks by Signing Up to our 100% Free Email Newsletter!
|
|
© 2021 MJ Capital, LLC | All rights reserved